There are no products in your shopping cart.
A survey for UK-based colposcopists about whether there is enough information available for women who are referred.
Opportunities to work with other organisations and researchers:
The Royal Marsden Hospital with the Institute of Cancer Research are conducting a trial looking at whether Magnetic Resonance guided High Intensity Focused Ultrasound (MRgHIFU) is useful for the treatment of symptoms of women's cancers that have come back (e.g. pain, bleeding) in cases where other treatments (e.g. radiotherapy and chemotherapy) have not worked. Prof Nandita deSouza's team is recruiting eligible patients for the trial which is taking place at the Royal Marsden Hospital in Sutton, London. Please click here for more information or email the MRgHIFU Clinical Research Fellow Dr Georgios Imseeh ([email protected]) or call 020 8661 3119.
Clatterbridge Cancer Centre with the University of Liverpool are conducting a trial called COMICE looking at whether olaparib and cediranib can improve treatment for cancer of the cervix that has spread or come back. The trial will take place in participating hospitals around the UK and are planning to recruit eligible patients until November 2019. In this trial, some people have cediranib and olaparib and some have dummy drugs (placebo). Please click here for more information or email COMICE Trial Coordinator Karen Scott [email protected].
Help design a study to improve healthcare for women with gynaecological symptoms. This is a study for women aged 18 to 64 who have had any bleeding between periods or after sex in the past 2 years. Contact Alex Castanon on [email protected] to find out more.
The National Cancer Research Institute - Priority Setting Partnership: A survey asking questions about what people living with and beyond cancer feel are the most important questions for researchers to answer.